BlackThorn Therapeutics
A biopharmaceutical company developing neurobehavioural therapeutic treatments using artificial intelligence and clinical neuroscience.
All edits by Alexander Leirvåg
Edits on 29 Jun, 2020
Alexander Leirvåg
Edits made to:
Article (+30/-30 characters)
Article
On October 20, 2016 BlackThorn Therapeutics announced raising $40 million in series A funding from ARCH Venture Partners (lead investor), Mercury Fund, Johnson & Johnson Innovation, Altitude Life Science VenturesAltitude Life Science Ventures, and Alexandria Real Estate Equities. The company plans on using their series A funding to continue developing targeted and novel treatments for neurobehavioral disorders.
Find more companies like BlackThorn Therapeutics
Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
By using this site, you agree to our Terms of Service.